Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Naoki MitaTakuji IwashitaHironao IchikawaYuhei IwasaShinya UemuraKatsutoshi MuraseMasahito ShimizuPublished in: Journal of clinical medicine (2021)
Conversion surgery achieved long-term survival in patients with UAPC who were treated with the first-line mFX, although controversy still remained.